Source: Materials Science & Engineering C. Unidade: FCFRP
Subjects: QUIMIOTERAPIA, ÁCIDO FÓLICO, NEOPLASIAS OVARIANAS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZ, Marcela Tavares et al. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Materials Science & Engineering C, v. 105, p. e110038, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2019.110038. Acesso em: 19 out. 2024.APA
Luiz, M. T., Abriata, J. P., Raspantini, G. L., Tofani, L. B., Fumagalli, F., Melo, S. M. G. de, et al. (2019). In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Materials Science & Engineering C, 105, e110038. doi:10.1016/j.msec.2019.110038NLM
Luiz MT, Abriata JP, Raspantini GL, Tofani LB, Fumagalli F, Melo SMG de, Emery F da S, Swiech K, Marcato PD, Lee R, Marchetti JM. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy [Internet]. Materials Science & Engineering C. 2019 ; 105 e110038.[citado 2024 out. 19 ] Available from: https://doi.org/10.1016/j.msec.2019.110038Vancouver
Luiz MT, Abriata JP, Raspantini GL, Tofani LB, Fumagalli F, Melo SMG de, Emery F da S, Swiech K, Marcato PD, Lee R, Marchetti JM. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy [Internet]. Materials Science & Engineering C. 2019 ; 105 e110038.[citado 2024 out. 19 ] Available from: https://doi.org/10.1016/j.msec.2019.110038